PT  - JOURNAL ARTICLE
AU  - Jonathan Clarke
AU  - Renata Puertas
AU  - Aachal Kotecha
AU  - Paul J Foster
AU  - Keith Barton
TI  - Virtual clinics in glaucoma care: face-to-face versus remote decision-making
AID  - 10.1136/bjophthalmol-2016-308993
DP  - 2017 Jul 01
TA  - British Journal of Ophthalmology
PG  - 892--895
VI  - 101
IP  - 7
4099  - http://bjo.bmj.com/content/101/7/892.short
4100  - http://bjo.bmj.com/content/101/7/892.full
SO  - Br J Ophthalmol2017 Jul 01; 101
AB  - Background/aims To examine the agreement in clinical decisions of glaucoma status made in a virtual glaucoma clinic with those made during a face-to-face consultation.Methods A trained nurse and technicians entered data prospectively for 204 patients into a proforma. A subsequent face-to-face clinical assessment was completed by either a glaucoma consultant or fellow. Proformas were reviewed remotely by one of two additional glaucoma consultants, and 12 months later, by the clinicians who had undertaken the original clinical examination. The interobserver and intraobserver decision-making agreements of virtual assessment versus standard care were calculated.Results We identified adverse disagreement between face-to-face and virtual review in 7/204 (3.4%, 95% CI 0.9% to 5.9%) patients, where virtual review failed to predict a need to accelerated follow-up identified in face-to-face review. Misclassification events were rare, occurring in 1.9% (95% CI 0.3% to 3.8%) of assessments. Interobserver κ (95% CI) showed only fair agreement (0.24 (0.04 to 0.43)); this improved to moderate agreement when only consultant decisions were compared against each other (κ=0.41 (0.16 to 0.65)). The intraobserver agreement κ (95% CI) for the consultant was 0.274 (0.073 to 0.476), and that for the fellow was 0.264 (0.031 to 0.497).Conclusions The low rate of adverse misclassification, combined with the slowly progressive nature of most glaucoma, and the fact that patients will all be regularly reassessed, suggests that virtual clinics offer a safe, logistically viable option for selected patients with glaucoma.